Motor Evoked Potentials With Modified Facilitation Technique
NCT ID: NCT03646929
Last Updated: 2021-05-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
81 participants
INTERVENTIONAL
2017-12-20
2019-01-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Real-Time Functional Magnetic Resonance Imaging Neurofeedback for Regulation of Psychophysiological Functions
NCT01921088
Brain Activity Changes Following Neuroproprioceptive Physiotherapy in Multiple Sclerosis
NCT04448444
Cognitive-motor Dual Task Training in Patients With Multiple Sclerosis
NCT04619953
Psychometric Properties Upper Limb Function Measures Multiple Sclerosis
NCT02339675
Auditory-motor Coupling in Multiple Sclerosis With Cerebellar Lesions
NCT04639401
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
healthy individuals and patients with multiple sclerosis
MEP in healthy individuals and patients with multiple sclerosis are measured using standard facilitation technique
MEP using standard facilitation technique
measuring of MEP using standard facilitation technique according to the Guidelines of International Federation of Clinical Neurophysiology
patients with multiple sclerosis
MEP in patients with multiple sclerosis are measured using modified facilitation technique
MEP using standard facilitation technique
measuring of MEP using standard facilitation technique according to the Guidelines of International Federation of Clinical Neurophysiology
MEP using modified facilitation technique
measuring of MEP using modified facilitation technique (application of additional 8-12x magnetic stimuli for arms and legs)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MEP using standard facilitation technique
measuring of MEP using standard facilitation technique according to the Guidelines of International Federation of Clinical Neurophysiology
MEP using modified facilitation technique
measuring of MEP using modified facilitation technique (application of additional 8-12x magnetic stimuli for arms and legs)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Between 18 and 65 year of age
* No neurologic or psychiatric comorbidity requiring continous treatment
* No previous damage of central nervous System
* Ability to understand the purpose and risks of the study, provide signed and dated informed consent
* Between 18 and 65 year of age
* patients with inflammatory diseases of the central nervous system (CNS) or multiple sclerosis appointed for routine MEP diagnostic at the Department of Clinical Neurophysiology, University Hospital Basel
Exclusion Criteria
* Known disease of the peripheral nervous system (polyneuropathy)
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Basel, Switzerland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Martin Hardmeier, PD Dr. med
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Basel, Switzerland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dep. of Neurology and Clinical Neurophysiology , Hospital of the University of Basel
Basel, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-01893; me18Hardmeier
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.